Combination of Menopur and Rekovelle for first IVF cycle
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests a combination of two fertility medications (Menopur and Rekovelle) to see if they work well together during your first IVF cycle. It may be a good option if you have certain types of infertility and meet the health requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old.
- You have a diagnosis of unexplained infertility, blocked tubes, mild endometriosis (stage I or II), or a male factor issue.
- You have regular periods (every 24 to 35 days) and both ovaries.
- This is your first IVF or ICSI cycle.
- You are not using donor eggs, and your partner or donor provides sperm (fresh or frozen).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a fixed dose of the hormone follitropin delta (Rekovelle) to stimulate the ovaries before intrauterine insemination (IUI). It aims to see if this approach works well for women with regular cycles who are starting IUI for the first time.
This trial tests two different intensities of ovarian stimulation for women undergoing IVF with genetic testing of embryos. It aims to see which approach leads to more healthy embryos ready for transfer.
This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This study tests different medication approaches to help women who had a low number of eggs in a previous IVF cycle produce more eggs this time. The goal is to find a better stimulation method for women with this 'low response' pattern.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
Hear when a new IVF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.